Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Deborah A. Mulford, M.D.
Deborah A. Mulford, M.D.

Deborah A. Mulford, M.D.

Medicine — Hematology/Oncology — Hematology

Accepting New Patients

Deborah A. Mulford, M.D.

Medicine — Hematology/Oncology — Hematology

Accepting New Patients


Locations

Wilmot Cancer Institute
601 Elmwood Ave.
Rochester, NY 14642
Get Directions

phone

Appointments

(585) 275-5823

print

Fax

(585) 273-1042

About Me

I was drawn to the field of oncology because it allows me to treat the whole person. The number of new and effective cancer therapies we can offer patients excites me, and it is incredibly rewarding to experience positive results with patients and families.

My practice style is patient- and family-focused. I work closely with a multidisciplinary team to determine the best, evidence-based treatment option for each individual. My primary focus is in the treatment of cancers originating from the lung and/or head and neck region. I am a native Rochesterian and am proud to have attended the University of Rochester for medical school.

Conditions I Treat:

- Head and neck cancers
- Lung cancer
- Other malignancies

Credentials

Education:

MD | University of Rochester — 1999

Post-doctoral Training & Residency:

Fellowship in Hematology/Oncology at Memorial Sloan-Kettering Cancer Center — 2002 - 2005
Internship in Internal Medicine at New York University School of Medicine — 1999 - 2000
Residency in Internal Medicine at New York University School of Medicine — 2000 - 2002

Research

Publications:

Gajra A, Ali H, Amiri KI, Karim NA, Matrana MR, Mulford D, Ong TJ, Sanford A, Santos ES, Socinski MA, Spigel DR. "PS01.08: ABOUND.PS2 Interim Safety Results: nab-Paclitaxel/Carboplatin Followed by nab-Paclitaxel in NSCLC Patients with ECOG PS of 2: Topic: Medical Oncology." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.. 2016 Nov 0; 11(11S):S274. Epub 2016 Oct 28.

Advani AS, McDonough S, Copelan E, Willman C, Mulford DA, List AF, Sekeres MA, Othus M, Appelbaum FR. "SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia." British journal of haematology.. 2014 Oct 0; 167(2):233-7. Epub 2014 Jul 18.

Liesveld JL, O'Dwyer K, Walker A, Becker MW, Ifthikharuddin JJ, Mulford D, Chen R, Bechelli J, Rosell K, Minhajuddin M, Jordan CT, Phillips GL. "A phase I study of decitabine and rapamycin in relapsed/refractory AML." Leukemia research.. 2013 Dec 0; 37(12):1622-7. Epub 2013 Sep 08.

View All Publications